BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
Open Access
- 3 September 2015
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 28 (3), 370-383
- https://doi.org/10.1016/j.ccell.2015.08.001
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Relief of Feedback Inhibition of HER3 Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in BRAF-Mutant Thyroid CarcinomasCancer Discovery, 2013
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with VemurafenibCancer Discovery, 2012
- Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistanceNature Communications, 2012
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)Nature, 2011
- Feedback regulation of EGFR signalling: decision making by early and delayed loopsNature Reviews Molecular Cell Biology, 2011
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- Mutations of the BRAF gene in human cancerNature, 2002
- Autoregulation of the Raf-1 serine/threonine kinaseProceedings of the National Academy of Sciences of the United States of America, 1998
- Oligomerization activates c-Raf-1 through a Ras-dependent mechanismNature, 1996
- SOS Phosphorylation and Disassociation of the Grb2-SOS Complex by the ERK and JNK Signaling PathwaysJournal of Biological Chemistry, 1996